10% OFF EVERYTHING
Ends July 31Shop the sale
Third-party tested
Discreet shipping
Back to Research Blog
Inflammation Research

KPV: An α-MSH-Derived Tripeptide in Inflammatory-Pathway Research

KPV is the C-terminal tripeptide of α-melanocyte-stimulating hormone. This overview surveys its melanocortin-independent modulation of inflammatory signaling and the epithelial-transport research that distinguishes it.

Purely Peptides Research TeamJuly 21, 20267 min read
KPValpha-MSHtripeptideNF-kBPepT1inflammation research
Research Use Only. All compounds discussed are sold exclusively for laboratory and in vitro research purposes. Nothing on this page constitutes medical advice or recommendation for human use.

KPV (Lys-Pro-Val) is the C-terminal tripeptide fragment of α-melanocyte-stimulating hormone (α-MSH). Despite its small size, it is a well-studied tool compound in inflammatory-signaling research, notable because much of its activity appears to be independent of the classical melanocortin receptors that mediate α-MSH signaling. That property has made it a useful probe for dissecting receptor-dependent from receptor-independent anti-inflammatory pathways.

NF-κB Pathway Modulation

The most characterized line of KPV research concerns intracellular modulation of the NF-κB signaling cascade. In cultured epithelial and immune cells, KPV has been reported to reduce activation of NF-κB and downstream pro-inflammatory cytokine transcription. Because this occurs without a strict requirement for MC1R/MC3R engagement, KPV is often used to study the intracellular arm of α-MSH-related anti-inflammatory activity.

PepT1-Mediated Epithelial Uptake

A distinctive feature of KPV research is its transport. As a di/tripeptide, KPV can be taken up by intestinal epithelial cells via the PepT1 (SLC15A1) oligopeptide transporter. This transporter-mediated entry has made KPV a frequent model compound in studies of intestinal epithelial inflammation, where PepT1 expression is itself a variable of interest.

Research Applications

  • NF-κB and pro-inflammatory cytokine pathway assays
  • Melanocortin-independent anti-inflammatory mechanism studies
  • PepT1/SLC15A1 oligopeptide-transport research
  • Preclinical intestinal-epithelial inflammation models
  • Structure-activity comparison against the parent α-MSH sequence

References

  1. Dalmasso G, Charrier-Hisamuddin L, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology 2008. PMID: 18061177.
  2. Kannengiesser K, Maaser C, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis 2008. PMID: 18092346.

This article summarizes publicly available research for educational purposes and does not constitute medical advice, a therapeutic claim, or a recommendation for human use. Products referenced are sold for laboratory research use only.

Research Compounds Discussed